Smoking worsens the prognosis in multiple sclerosis

First Published July 16, 2008 Research Article Find in PubMed

Authors

Department of Neurology, Umeå University Hospital, Umeå, Sweden
by this author
,
Department of Public Health and Clinical Medicine, Epidemiology and Public Health Sciences, Umeå University, Umeå, Sweden
by this author
First Published Online: July 16, 2008

Objective

To estimate the effect of smoking on the risk for progression in multiple sclerosis (MS).

Methods

Self-reported data were used on smoking habits in 122 incident cases with disability assessments made after a median of 6 years disease duration.

Results

Ever smokers were more likely to have progressive disease compared with never smokers (P < 0.01). This was most pronounced in ever smokers with early smoking debut (≤15 years of age) for whom progressive disease was significantly more likely and occurred at an earlier age, compared with those with later smoking debut (P < 0.01 for both) or never smokers (P < 0.01 for both). Earlysmoking start also predisposed to a progressive disease from onset when compared with never smokers (P = 0.012). A multivariate Cox regression analysis of sex, age at disease onset (above vs. under median) and smoking (ever vs. never) status showed that cases with late disease onset had three times higher risk and ever smokers had twice as high a risk for progression.

Conclusion

Past smoking is associated with a worsened prognosis in MS. The negative effect from smoking is most obvious in ever smokers with early smoking debut, which also affects MS phenotype significantly.

1 Paty DW  Ebers G  . Multiple sclerosis, vol. 50. F.A. Davis Company Philadelphia , 1998.
Google Scholar
2 Steinman L  . Multiple sclerosis: a two-stage disease . Nat Immunol 2001; 2: 762764 .
Google Scholar | Crossref | Medline | ISI
3 Confavreux C  Vukusic S  Moreau T  Adeleine P  . Relapses and progression of disability in multiple sclerosis . N Engl J Med 2000; 343: 14301438 .
Google Scholar | Crossref | Medline | ISI
4 Sopori M  . Effects of cigarette smoke on the immune system . Nat Rev Immunol 2002; 2: 372377 .
Google Scholar | Crossref | Medline | ISI
5 Brix TH  Hansen PS  Kyvik KO  Hegedus L  . Cigarette smoking and risk of clinically overt thyroid disease: a population-based twin case-control study . Arch Intern Med 2000; 160: 661666 .
Google Scholar | Medline
6 Majka DS  Holers VM  . Cigarette smoking and the risk of systemic lupus erythematosus and rheumatoid arthritis . Ann Rheum Dis 2006; 65: 561563 .
Google Scholar | Crossref | Medline | ISI
7 Hernan MA  Olek MJ  Ascherio A  . Cigarette smoking and incidence of multiple sclerosis . Am J Epidemiol 2001; 154: 6974 .
Google Scholar | Crossref | Medline | ISI
8 Nordquist LT  Simon GR  Cantor A  Alberts WM  Bepler G  . Improved survival in never-smokers vs current smokers with primary adenocarcinoma of the lung . Chest 2004; 126: 347351 .
Google Scholar | Crossref | Medline | ISI
9 van Domburg RT  Meeter K  van Berkel DF  Veldkamp RF  van Herwerden LA  Bogers AJ  . Smoking cessation reduces mortality after coronary artery bypass surgery: a 20-year follow-up study . J Am Coll Cardiol 2000; 36: 878883 .
Google Scholar | Crossref | Medline | ISI
10 Hernan MA  Jick SS  Logroscino G  Olek MJ  Ascherio A  Jick H  . Cigarette smoking and the progression of multiple sclerosis . Brain 2005; 128: 14611465 .
Google Scholar | Crossref | Medline | ISI
11 Sundstrom P  Nystrom L  Forsgren L  . Incidence (1988-97) and prevalence (1997) of multiple sclerosis in Vasterbotten County in northern Sweden . J Neurol Neurosurg Psychiatry 2003; 74: 2932 .
Google Scholar | Crossref | Medline | ISI
12 Sundstrom P  Svenningsson A  Nystrom L  Forsgren L  . Clinical characteristics of multiple sclerosis in Vasterbotten County in northern Sweden . J Neurol Neurosurg Psychiatry 2004; 75: 711716 .
Google Scholar | Crossref | Medline | ISI
13 Roxburgh RH  Seaman SR  Masterman T  . Multiple Sclerosis Severity Score: using disability and disease duration to rate disease severity . Neurology 2005; 64: 11441151 .
Google Scholar | Crossref | Medline | ISI
14 Giovino GA  . Epidemiology of tobacco use in the United States . Oncogene 2002; 21: 73267340 .
Google Scholar | Crossref | Medline | ISI
15 Thompson AJ  Polman CH  Miller DH  . Primary progressive multiple sclerosis . Brain 1997; 120: 10851096 .
Google Scholar | Crossref | Medline | ISI
16 Koch M  van Harten A  Uyttenboogaart M  De Keyser J  . Cigarette smoking and progression in multiple sclerosis . Neurology 2007; 69: 15151520 .
Google Scholar | Crossref | Medline | ISI
17 Lawlor DA  O'Callaghan MJ  Mamun AA  Williams GM  Bor W  Najman JM  . Early life predictors of adolescent smoking: findings from the Mater-University study of pregnancy and its outcomes . Paediatr Perinat Epidemiol 2005; 19: 377387 .
Google Scholar | Crossref | Medline | ISI
18 Navarro HA  Basta PV  Seidler FJ  Slotkin TA  . Adolescent nicotine: deficits in immune function . Brain Res Dev Brain Res 2001; 130: 253256 .
Google Scholar | Crossref | Medline
19 Ascherio A  Munger KL  . Environmental risk factors for multiple sclerosis. Part I: the role of infection . Ann Neurol 2007; 61: 288299 .
Google Scholar | Crossref | Medline | ISI
20 Trojano M  Liguori M  Bosco Zimatore G  . Age-related disability in multiple sclerosis . Ann Neurol 2002; 51: 475480 .
Google Scholar | Crossref | Medline | ISI
21 Confavreux C  Vukusic S  . Age at disability milestones in multiple sclerosis . Brain 2006; 129: 595605 .
Google Scholar | Crossref | Medline | ISI
22 Lambert C  McCue J  Portas M  . Acrolein in cigarette smoke inhibits T-cell responses . J Allergy Clin Immunol 2005; 116: 916922 .
Google Scholar | Crossref | Medline | ISI
23 Wood PL  Khan MA  Moskal JR  . The concept of “aldehyde load” in neurodegenerative mechanisms: cytotoxicity of the polyamine degradation products hydrogen peroxide, acrolein, 3-aminopropanal, 3-acetamidopropanal and 4-aminobutanal in a retinal ganglion cell line . Brain Res 2007; 1145: 150156 .
Google Scholar | Crossref | Medline | ISI
24 Trapp BD  Bo L  Mork S  Chang A  . Pathogenesis of tissue injury in MS lesions . J Neuroimmunol 1999; 98: 4956 .
Google Scholar | Crossref | Medline | ISI
25 Rejdak K  Eikelenboom MJ  Petzold A  . CSF nitric oxide metabolites are associated with activity and progression of multiple sclerosis . Neurology 2004; 63: 14391445 .
Google Scholar | Crossref | Medline | ISI

Access content

To read the fulltext, please use one of the options below to sign in or purchase access.
  • Access Options

    My Account

    Welcome
    You do not have access to this content.

    Chinese Institutions / 中国用户

    Click the button below for the full-text content

    请点击以下获取该全文

    Institutional Login

    Purchase Content

    24 hours online access to download content

    Added to Cart

    Cart is full

    There is currently no price available for this item in your region.

    Research off-campus without worrying about access issues. Find out about Lean Library here


Purchase

MSJ-article-ppv for GBP32.00
MSJ-article-ppv for $41.50
Single Issue 24 hour E-access for GBP319.06
Single Issue 24 hour E-access for $397.14